Vision Care Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4410310
  • Report
  • 342 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Acuity Polymers Inc
  • Bausch & Lomb Inc
  • Eyenovations
  • Monash University
  • Presbia Plc
  • University of Auckland
  • MORE
Vision Care Devices - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Vision Care Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Vision Care Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vision Care Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vision Care Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vision Care Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vision Care Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acuity Polymers Inc
  • Bausch & Lomb Inc
  • Eyenovations
  • Monash University
  • Presbia Plc
  • University of Auckland
  • MORE
1 Table of Contents

2 Introduction
2.1 Vision Care Devices Overview

3 Products under Development
3.1 Vision Care Devices - Pipeline Products by Stage of Development
3.2 Vision Care Devices - Pipeline Products by Segment
3.3 Vision Care Devices - Pipeline Products by Territory
3.4 Vision Care Devices - Pipeline Products by Regulatory Path
3.5 Vision Care Devices - Pipeline Products by Estimated Approval Date
3.6 Vision Care Devices - Ongoing Clinical Trials

4 Vision Care Devices - Pipeline Products under Development by Companies
4.1 Vision Care Devices Companies - Pipeline Products by Stage of Development
4.2 Vision Care Devices - Pipeline Products by Stage of Development

5 Vision Care Devices Companies and Product Overview
5.1 Acuity Polymers Inc Company Overview
5.2 Adventus Technology Inc Company Overview
5.3 Aeon Astron Corporation Company Overview
5.4 Alcon Laboratories Inc Company Overview
5.5 Allotex Inc Company Overview
5.6 Apeliotus Ophthalmics (Inactive) Company Overview
5.7 Auburn University Company Overview
5.8 Axcelon Biopolymers Corp. Company Overview
5.9 Bar-Ilan University Company Overview
5.10 Bausch & Lomb Inc Company Overview
5.11 Bionic Sight LLC Company Overview
5.12 Bionic Vision Australia Company Overview
5.13 Bionode LLC Company Overview
5.14 Children's Hospital Boston Company Overview
5.15 Consejo Superior de Investigaciones Cientificas Company Overview
5.16 CooperVision Inc Company Overview
5.17 Cornea Biosciences Company Overview
5.18 DeepOptics Company Overview
5.19 eSight Corp Company Overview
5.20 Euclid Systems Corp Company Overview
5.21 e-Vision Medical Devices, Inc. Company Overview
5.22 Eyenovations Company Overview
5.23 EyeYon Medical Company Overview
5.24 Forschungszentrum Julich GmbH Company Overview
5.25 iBionics Inc Company Overview
5.26 Imperial College London Company Overview
5.27 Institute of Photonic Sciences Company Overview
5.28 iSTAR Medical SA Company Overview
5.29 John Hopkins University Company Overview
5.30 Johnson & Johnson Vision Care Inc Company Overview
5.31 Massachusetts Eye and Ear Infirmary Company Overview
5.32 McGill University Company Overview
5.33 Mercy Research and Development Company Overview
5.34 Meta Biomed Co Ltd Company Overview
5.35 Microbiosensor Ltd Company Overview
5.36 Monash University Company Overview
5.37 Nano Retina, Inc. Company Overview
5.38 Novartis AG Company Overview
5.39 Ocular Dynamics, LLC Company Overview
5.40 Ocutec Ltd Company Overview
5.41 OPIA Technologies SAS Company Overview
5.42 Oxsight Ltd Company Overview
5.43 PixelOptics Inc Company Overview
5.44 Pixium Vision Company Overview
5.45 Presbia Plc Company Overview
5.46 Queensland University of Technology Company Overview
5.47 Refocus Group Inc Company Overview
5.48 RetMap Inc Company Overview
5.49 ReVision Optics Inc Company Overview
5.50 Royal College of Surgeons in Ireland Company Overview
5.51 Stanford University Company Overview
5.52 Studio Oculistico Gualdi Company Overview
5.53 SynergEyes Inc Company Overview
5.54 Tel Aviv University Company Overview
5.55 The University of New South Wales Company Overview
5.56 The Wilmer Eye Institute at Johns Hopkins Company Overview
5.57 UltraVision CLPL Company Overview
5.58 University of Auckland Company Overview
5.59 University of California Irvine Company Overview
5.60 University of California San Diego Company Overview
5.61 University of Chicago Medical Center Company Overview
5.62 University of Florida Company Overview
5.63 University of Illinois at Chicago Company Overview
5.64 University of Oxford Company Overview
5.65 University of South Florida Company Overview
5.66 University of Tennessee Company Overview
5.67 University of Tubingen Company Overview
5.68 University of Valencia Company Overview
5.69 University of Washington Company Overview
5.70 Valeant Pharmaceuticals International Inc Company Overview
5.71 Va-st Ltd Company Overview
5.72 Visioneering Technologies Inc Company Overview
5.73 VISTAKON Pharmaceuticals LLC Company Overview
5.74 Visus Technology Inc Company Overview
5.75 Weill Cornell Medical College Company Overview
5.76 Western University Company Overview
5.77 Yolia Health Company Overview
5.78 ZircLight Inc. Company Overview

6 Vision Care Devices - Recent Developments
6.1 Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts
6.2 Sep 12, 2017: eSight 3 Launches in Australia and New Zealand
6.3 Sep 12, 2017: Essilor Of America Unveils Three Innovative Lens Technologies With The Ultimate Lens Package
6.4 Sep 11, 2017: New Data Shows DAILIES TOTAL1 Multifocal Contact Lenses Are Comfortable and Less Dry at the End of the Day
6.5 Sep 11, 2017: New Data Shows DAILIES TOTAL1 Multifocal Contact Lenses Are Comfortable and Less Dry at the End of the Day
6.6 Sep 08, 2017: Essilor is Gold Sponsor of the 2 nd World Congress of Optometry
6.7 Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs
6.8 Sep 06, 2017: ReVision Optics Names Two Ophthalmic Experts as Medical Monitors to Oversee Raindrop Near Vision Inlay Clinical Performance
6.9 Sep 06, 2017: Optometrist Chooses the KAMRA Corneal Inlay for Her Solution to Reading Glasses
6.10 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
6.11 Aug 31, 2017: The Cooper Companies Announces Third Quarter 2017 Results
6.12 Aug 30, 2017: Alcon revamps the packaging for its AIR OPTIX brand monthly replacement contact lenses
6.13 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
6.14 Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand
6.15 Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results
6.16 Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results
6.17 Aug 09, 2017: Bausch + Lomb Receives 510(K) Clearance From FDA for the Therapeutic use of Boston XO Materials
6.18 Aug 09, 2017: Bausch + Lomb Receives 510(K) Clearance From FDA for the Therapeutic use of Boston XO2 Materials
6.19 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results
6.20 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results
6.21 Aug 02, 2017: Essilor wins Sustainable Business Award for its commitment to the United Nation’s Sustainable Development Goals
6.22 Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island
6.23 Jul 28, 2017: Essilor International: Resilient First Half
6.24 Jul 28, 2017: Topcon: Notice of Changes of Executive Officers
6.25 Jul 27, 2017: Pixium Vision Announces H1 2017 Financial Results and Provides an Update on Its Activities
6.26 Jul 27, 2017: Hoya Reports First Quarter Financial Results
6.27 Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina
6.28 Jul 24, 2017: Antitrust process update for the proposed combination between Essilor and Luxottica
6.29 Jul 21, 2017: Sikka Software Wins API World 2017 Award for Health API, Leads the Way in Retail Healthcare Innovation
6.30 Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno
6.31 Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
6.32 Jul 18, 2017: Visioneering Technologies Appoints Gary Sacks as Executive Territory Manager For New York/Western Massachusetts
6.33 Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey
6.34 Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco
6.35 Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition
6.36 Jul 06, 2017: Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX Contact Lenses
6.37 Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Vision Care Devices - Pipeline Products by Stage of Development
Table 2: Vision Care Devices - Pipeline Products by Segment
Table 3: Vision Care Devices - Pipeline Products by Territory
Table 4: Vision Care Devices - Pipeline Products by Regulatory Path
Table 5: Vision Care Devices - Pipeline Products by Estimated Approval Date
Table 6: Vision Care Devices - Ongoing Clinical Trials
Table 7: Vision Care Devices Companies - Pipeline Products by Stage of Development
Table 8: Vision Care Devices - Pipeline Products by Stage of Development
Table 9: Acuity Polymers Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Acuity 58 - Product Status
Table 11: Acuity 58 - Product Description
Table 12: Acuity 85 - Product Status
Table 13: Acuity 85 - Product Description
Table 14: Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Corneal Onlay - Product Status
Table 16: Corneal Onlay - Product Description
Table 17: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Biolens - Product Status
Table 19: Biolens - Product Description
Table 20: Contact Lens - Product Status
Table 21: Contact Lens - Product Description
Table 22: Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Status
Table 24: AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - Product Description
Table 25: AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - Product Status
Table 26: AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - Product Description
Table 27: Dailies Total 1 Colors SiHy Lens - Product Status
Table 28: Dailies Total 1 Colors SiHy Lens - Product Description
Table 29: Dailies Total 1 Toric SiHy Lens - Product Status
Table 30: Dailies Total 1 Toric SiHy Lens - Product Description
Table 31: Smart Contact Lens - Diabetes - Product Status
Table 32: Smart Contact Lens - Diabetes - Product Description
Table 33: Weekly WG SiHy Lens - Product Status
Table 34: Weekly WG SiHy Lens - Product Description
Table 35: Alcon Laboratories Inc - Ongoing Clinical Trials Overview
Table 36: AIR OPTIX Plus HydraGlyde Monthly Replacement Contact Lenses - Overnight And Flexible Wear - One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors
Table 37: AIR OPTIX Plus HydraGlyde Monthly Replacement Clear And Color Lens - One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors
Table 38: Allotex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Allotex Natural Allograft Lens - Product Status
Table 40: Allotex Natural Allograft Lens - Product Description
Table 41: Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Comfort Lens - Product Status
Table 43: Comfort Lens - Product Description
Table 44: Contact Lens - Glaucoma - Product Status
Table 45: Contact Lens - Glaucoma - Product Description
Table 46: Auburn University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Smart Contact Lenses - Product Status
Table 48: Smart Contact Lenses - Product Description
Table 49: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 50: MC - PHEMA Based Contact Lens - Product Status
Table 51: MC - PHEMA Based Contact Lens - Product Description
Table 52: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Bionic Contact Lens - Product Status
Table 54: Bionic Contact Lens - Product Description
Table 55: Vision Substitution Device - Product Status
Table 56: Vision Substitution Device - Product Description
Table 57: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Bausch + Lomb ULTRA Astigmatism Contact Lens - Product Status
Table 59: Bausch + Lomb ULTRA Astigmatism Contact Lens - Product Description
Table 60: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Status
Table 61: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Description
Table 62: Ultra Plus Powers Lens - Product Status
Table 63: Ultra Plus Powers Lens - Product Description
Table 64: Ultra Toric Lens - Product Status
Table 65: Ultra Toric Lens - Product Description
Table 66: Bionic Sight LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Neuro-Prosthetic Device - Product Status
Table 68: Neuro-Prosthetic Device - Product Description
Table 69: Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview
Table 70: High-Acuity Device With 1024 Electrodes - Product Status
Table 71: High-Acuity Device With 1024 Electrodes - Product Description
Table 72: High-Acuity Device With 256 Electrodes - Product Status
Table 73: High-Acuity Device With 256 Electrodes - Product Description
Table 74: Wide-View Device With 24-channel - Product Status
Table 75: Wide-View Device With 24-channel - Product Description
Table 76: Wide-View Device With 44-channel - Product Status
Table 77: Wide-View Device With 44-channel - Product Description
Table 78: Wide-View Device With 98 Electrodes - Product Status
Table 79: Wide-View Device With 98 Electrodes - Product Description
Table 80: Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Contact Lenses - Product Status
Table 82: Contact Lenses - Product Description
Table 83: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Contact Lens Drug Delivery Device - Product Status
Table 85: Contact Lens Drug Delivery Device - Product Description
Table 86: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Reduced Optical Instrument - Product Status
Table 88: Reduced Optical Instrument - Product Description
Table 89: CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Biofinity Energys - Product Status
Table 91: Biofinity Energys - Product Description
Table 92: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status
Table 93: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description
Table 94: SiH Multifocal - Product Status
Table 95: SiH Multifocal - Product Description
Table 96: CooperVision Inc - Ongoing Clinical Trials Overview
Table 97: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses
Table 98: MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial
Table 99: Cornea Biosciences Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Bioengineered Cornea - Product Status
Table 101: Bioengineered Cornea - Product Description
Table 102: DeepOptics Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Omnifocal Adaptive Lens - Product Status
Table 104: Omnifocal Adaptive Lens - Product Description
Table 105: eSight Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 106: evSpex - Product Status
Table 107: evSpex - Product Description
Table 108: Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Drug-Eluting Contact Lenses - Product Status
Table 110: Drug-Eluting Contact Lenses - Product Description
Table 111: e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Electronic Contact Lens - Product Status
Table 113: Electronic Contact Lens - Product Description
Table 114: Electronic Focusing Eyeglasses - Product Status
Table 115: Electronic Focusing Eyeglasses - Product Description
Table 116: Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
Table 117: Drug Dispensing Contact Lens - Product Status
Table 118: Drug Dispensing Contact Lens - Product Description
Table 119: EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 120: DSPEK - Product Status
Table 121: DSPEK - Product Description
Table 122: Hyper-CL - Drug Delivery - Product Status
Table 123: Hyper-CL - Drug Delivery - Product Description
Table 124: Forschungszentrum Julich GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Retinal Electrode - Product Status
Table 126: Retinal Electrode - Product Description
Table 127: iBionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 128: iBIONICS Diamond Eye - Product Status
Table 129: iBIONICS Diamond Eye - Product Description
Table 130: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Contact Lens - Product Status
Table 132: Contact Lens - Product Description
Table 133: Institute of Photonic Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table 134: SMARTLENS - Product Status
Table 135: SMARTLENS - Product Description
Table 136: iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 137: STARvue - Product Status
Table 138: STARvue - Product Description
Table 139: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Intra-corneal Implant - Product Status
Table 141: Intra-corneal Implant - Product Description
Table 142: Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 143: 1-DAY ACUVUE Multifocal Contact Lens - Product Status
Table 144: 1-DAY ACUVUE Multifocal Contact Lens - Product Description
Table 145: Anti-allergic Contact Lens - Product Status
Table 146: Anti-allergic Contact Lens - Product Description
Table 147: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Therapeutic Contact Lens - Product Status
Table 149: Therapeutic Contact Lens - Product Description
Table 150: McGill University Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Portable System - Amblyopia - Product Status
Table 152: Portable System - Amblyopia - Product Description
Table 153: Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview
Table 154: First Aid Lens - Product Status
Table 155: First Aid Lens - Product Description
Table 156: Healing Lens - Product Status
Table 157: Healing Lens - Product Description
Table 158: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Artificial Cornea - Product Status
Table 160: Artificial Cornea - Product Description

List of Figures
Figure 1: Vision Care Devices - Pipeline Products by Stage of Development
Figure 2: Vision Care Devices - Pipeline Products by Segment
Figure 3: Vision Care Devices - Pipeline Products by Territory
Figure 4: Vision Care Devices - Pipeline Products by Regulatory Path
Figure 5: Vision Care Devices - Pipeline Products by Estimated Approval Date
Figure 6: Vision Care Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Acuity Polymers Inc
  • Adventus Technology Inc
  • Aeon Astron Corporation
  • Alcon Laboratories Inc
  • Allotex Inc
  • Apeliotus Ophthalmics
  • Auburn University
  • Axcelon Biopolymers Corp.
  • Bar-Ilan University
  • Bausch & Lomb Inc
  • Bionic Sight LLC
  • Bionic Vision Australia
  • Bionode LLC
  • Children's Hospital Boston
  • Consejo Superior de Investigaciones Cientificas
  • CooperVision Inc
  • Cornea Biosciences
  • DeepOptics
  • eSight Corp
  • Euclid Systems Corp
  • e-Vision Medical Devices, Inc.
  • Eyenovations
  • EyeYon Medical
  • Forschungszentrum Julich GmbH
  • iBionics Inc
  • Imperial College London
  • Institute of Photonic Sciences
  • iSTAR Medical SA
  • John Hopkins University
  • Johnson & Johnson Vision Care Inc
  • Massachusetts Eye and Ear Infirmary
  • McGill University
  • Mercy Research and Development
  • Meta Biomed Co Ltd
  • Microbiosensor Ltd
  • Monash University
  • Nano Retina, Inc.
  • Novartis AG
  • Ocular Dynamics, LLC
  • Ocutec Ltd
  • OPIA Technologies SAS
  • Oxsight Ltd
  • PixelOptics Inc
  • Pixium Vision
  • Presbia Plc
  • Queensland University of Technology
  • Refocus Group Inc
  • RetMap Inc
  • ReVision Optics Inc
  • Royal College of Surgeons in Ireland
  • Stanford University
  • Studio Oculistico Gualdi
  • SynergEyes Inc
  • Tel Aviv University
  • The University of New South Wales
  • The Wilmer Eye Institute at Johns Hopkins
  • UltraVision CLPL
  • University of Auckland
  • University of California Irvine
  • University of California San Diego
  • University of Chicago Medical Center
  • University of Florida
  • University of Illinois at Chicago
  • University of Oxford
  • University of South Florida
  • University of Tennessee
  • University of Tubingen
  • University of Valencia
  • University of Washington
  • Valeant Pharmaceuticals International Inc
  • Va-st Ltd
  • Visioneering Technologies Inc
  • VISTAKON Pharmaceuticals LLC
  • Visus Technology Inc
  • Weill Cornell Medical College
  • Western University
  • Yolia Health
  • ZircLight Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll